GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

United Health Products UEEC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.04

+7.82%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−$2.7m

FY2016FY2025

Free cash flow

−$1.2m

FY2016FY2025

Shareholders' equity

−$3.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017FY2016
Revenue———$37,500$4,927$4,927$45,862$645,652$242,007
Research and development$269,867$355,936$598,810$624,564$666,388$666,388$76,951$19,936$19,936
Operating income−$2.3m−$2.0m−$2.5m−$2.8m−$6.1m−$6.1m−$6.0m−$1.5m−$517,475
Net income−$2.7m−$2.0m−$2.6m−$1.7m−$7.1m−$6.6m−$6.0m−$934,968−$535,735
Diluted earnings per share-0.01-0.01-0.01-0.01-0.03-0.04-0.13-0.03-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017FY2016
Total assets$316,698$269,979$284,643$350,528$217,100$93,472$125,977$813,560$196,962
Cash and short-term investments—$168,883$95,420$13,377$46,076—$31,273$189,942$29,367
Total liabilities$4.2m$2.7m$2.0m$2.4m$1.2m$997,277$478,677$1.1m$948,934
Debt$250,000$1.1m$755,989$687,644$559,952—$8,121$450,828$328,328
Shareholders' equity−$3.9m−$2.4m−$1.7m−$2.1m−$953,262−$903,805−$352,700−$261,265−$751,972
Shares outstanding249m249m245m230m222m178m46m31m608m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017FY2016
Cash from operations−$1.2m−$1.2m−$2.2m−$619,720−$1.3m−$1.8m−$1.3m−$645,900−$473,352
Capital spending——−$5−$40,500−$101,350−$101,350−$101,350−$101,350—
Free cash flow−$1.2m−$1.2m−$2.2m−$660,220−$1.4m−$1.9m−$1.4m−$747,250−$473,352

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−$166,850−$265,581−$264,723−$233,179−$268,356−$1.5m−$785,398−$391,903
Net income−$284,140−$315,842−$536,908−$285,594−$315,187−$1.5m−$814,112−$303,662
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.01-0.00-0.00
Total assets$247,985$248,825$316,698$94,313$81,538$104,542$269,979$150,629
Cash and short-term investments——————$168,883$43,783
Debt$502,567$250,000$250,000$1.4m$1.3m$1.1m$1.1m$916,780
Shareholders' equity−$4.4m−$4.2m−$3.9m−$3.3m−$3.2m−$2.9m−$2.4m−$2.1m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-7.0%-18.0%-1.3%
Net income16.5%-17.8%0.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-5.1-6.6-20.5-38.8-4.3-37.5-33.1-4.8-24.4-102.2
Price to sales————————35.4226.2

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-7%-73%-15%-57%-47%-2%98%-15%751%6%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.